American BioMed signs technology deal with US Surgical
This article was originally published in Clinica
Executive Summary
American BioMed has granted US Surgical a 90-day option to buy ABM's technologies for stents, atherectomy catheters and toposcopic catheters. US Surgical paid $2 million for the option and will pay an additional $12 million on completion of the agreement, which includes all intellectual property rights for the technologies. The sale is subject to approval by American BioMed shareholders.